Opinion

Video

Step Edits Associated with IV Iron Therapies

Panelists discuss how increasing insurance step edit requirements for high-dose IV iron formulations have created barriers to optimal patient care, requiring providers to implement strategic prior authorization processes and develop documentation protocols to demonstrate medical necessity while advocating for appropriate patient access to these medications.

Related Videos
1 expert in this video
1 expert in this video
Dr Margrit Wiesendanger
4 experts are featured in this series.
5 experts in this video
4 experts are featured in this series.
5 experts in this video
1 expert in this video
1 expert in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo